Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-080571
Filing Date
2023-07-13
Accepted
2023-07-13 08:30:05
Documents
2
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2321098d1_6k.htm 6-K 9802
2 EXHIBIT 99.1 tm2321098d1_ex99-1.htm EX-99.1 16781
  Complete submission text file 0001104659-23-080571.txt   27782
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 231085785
SIC: 2834 Pharmaceutical Preparations